Samarium doped ZnO (Sm-ZnO) nanocolumns were grown by wet chemical method and the doping effect of Sm3+ on visible light photocatalytic (PC) and photoluminescence (PL) properties of ZnO was investigated. Methylene blue (MB) and methyl orange (MO) were considered for the degradation study as a step initiated towards the remediation of industrial wastewater. Subsequent characterization studies by x-ray diffraction (XRD) and field emission scanning electron microscopy (FESEM) enumerate that the hexagonal-wurtzite structured Sm-ZnO is highly crystalline in nature and possesses hexagonal column like nano-architectures. Although, a charge imbalance exists between the ions, the substitutional effects of Sm3+ at Zn2+ sites have been observed from the XRD spectra and discussed by suitable mechanisms. FTIR measurement gives the information on the evolution of peaks related to metal-oxygen bond in Sm-ZnO which may be linked with Sm ions. PC measurement shows that the degradation efficiency of 95% can be achieved by Sm-ZnO photocatalysts in degrading MB and 91% for MO. Sm doping induces high charge separation efficiency and generation of OH ions in ZnO leading to such improvisation in degradation efficiency. The prepared Sm-ZnO nanocatalysts possess high degree of photostability and reusability even after fourth cycle of photodegradation. PL spectra show the suppression of the sharp and intense excitonic emission band of ZnO in Sm-ZnO due to low rated direct recombination of carriers. Incorporation of Sm3+ ends up with intrinsic defect mediated enhancement in the visible emissions especially in the blue, yellow and red region of light spectrum.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.